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A B S T R A C T
Plexiform neuroﬁbromas are benign tumors of the peripheral nerves and are usually considered
pathognomonic of neuroﬁbromatosis type 1. We discuss the case of a child who presented with a
forehead mass. Pathologic examination revealed a plexiform neuroﬁbroma of the supraorbital nerve. No
other signs or symptoms of neuroﬁbromatosis were identiﬁed. Although rare, plexiform neuroﬁbromas
may rarely occur as solitary lesions not associated with the neuroﬁbromatosis spectrum. It can be seen in
unusual anatomic location such as the supraorbital or forehead region and should be considered in the
diagnosis of soft tissue facial tumors.
 2013 The Authors. Published by Elsevier Ireland Ltd. 
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Neuroﬁbromatosis type I (NF-1) is a disease that results from
spontaneous mutations or familial transmitted mutations in the
NF-1 gene located on chromosome 17q11.2. These mutations
cause a loss-of-function in the protein neuroﬁbromin, which
typically functions as a tumor suppressor [1]. The criteria for
diagnosis of NF-1 was established by the NIH in 1988 and is listed
in Table 1 [2]. According to some authors, the triad of multiple
neuroﬁbromas, cafe´-au-lait macules, and especially of Lisch
nodules, is so reliable that their absence essentially excludes the
diagnosis of NF-1 [3,4].
Neuroﬁbromas are benign peripheral nerve sheath tumors that
present as focal cutaneous/subcutaneous or nodular/diffuse
plexiform lesions. Though we typically associate the more visible
cutaneous neuroﬁbromas with NF-1 (around 99% incidence),
plexiform neuroﬁbromas are also seen in up to 50% of NF-1
patients [1].* Corresponding author at: Facial Plastic and Reconstructive Surgery, Department
of Otolaryngology-Head and Neck Surgery, University of California, Davis Medical
Center, 2521 Stockton Boulevard, Suite 7200, Sacramento, CA 95817, United States.
Tel.: +1 916 734 2801; fax: +1 916 7035011.
E-mail address: tttollefson@gmail.com (T.T. Tollefson).
1871-4048   2013 The Authors. Published by Elsevier Ireland Ltd. 
http://dx.doi.org/10.1016/j.pedex.2013.11.002
Open access under the In this report, we discuss a case of a solitary plexiform
neuroﬁbroma of the supraorbital nerve.
2. Case presentation
A six-year-old Caucasian female presented with a slowly
growing, irregularly shaped left sided forehead mass present since
nine months of age. The patient’s parents considered the mass to
have occurred after a history of mild trauma to the forehead. A
biopsy in 2008 was noted to be a benign ﬁbroadipose tissue nodule.
Ultrasound imaging described the nodule as having a bilobed
hypoechoic consistency. There was no history of other lesions or
masses and no family history of similar lesions.
General physical examination including the ophthalmologic and
dermatologic exams of the patient was normal. Facial movement
and sensation were symmetric bilaterally. Palpation of the left
supraorbital foramen region revealed a ﬁrm, mobile left forehead
lesion, extending from the left lateral brow medially to midline and
measured 4.0  2.5 cm. Fixation to bone was not noted.
The patient was taken for surgery to remove the lesion. A
minimal incision was designed within the relaxed skin tension
lines of the forehead. Dissection through the galea aponeurosis
exposed a ﬂesh-colored, tubular mass that appeared to have
ﬁbroadipose appendages. The mass was seen to have small ﬁnger-
like extensions, which were traced until their termination. The
mass was removed off the periosteum and noted inferiorly to be
contiguous with the supraorbital nerve (Fig. 1). The tumor extent
was dissected under loupe magniﬁcation until the stalk of the
tumor was noted just outside the supraorbital notch. Consider-
ations for further dissection into the foramen might have includedCC BY-NC-ND license.
Table 1
NIH consensus guidelines: diagnostic criteria for neuroﬁbromatosis I [2] Two or
more of the following.
1. Six or more cafe´-au-lait macules that are (in greatest diameter)
>5 mm in pre-pubertal individuals
>15 mm in post-pubertal individuals
2. Two or more neuroﬁbromas of any type, or one plexiform neuroﬁbroma
3. Axillary/inguinal freckling
4. Optic glioma
5. Two or more Lisch nodules
6. Distinctive osseous lesion (i.e. sphenoid dysplasia or thinning of
long bone cortex with or without pseudoarthrosis)
7. First degree relative with NF-1
Fig. 1. View of forehead mass during surgical excision. Left eye at the top of the
image, hairline at the bottom. At the tip of the scissors, small ﬁnger-like extensions
can be seen extending into the supraorbital nerve.
Fig. 2. (a) 10 H&E stain of left forehead mass showing wavy bundles of collagen
with spindle-shaped neoplastic cells consistent with plexiform neuroﬁbroma. (b)
20 H&E cross-section through the plexiform neuroﬁbroma showing expanded
nerve branches and increased endoneurial matrix material.
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the foramen (as is completed in coronal approaches to the frontal
sinus). The initial pathologic frozen section suggested spindle cell
lesion, benign in nature.
Under microscope, the lesion showed a mass composed of
expanded nerve branches, with spindle-shaped neoplastic cells
arrayed between wavy bundles of collagen or in pools of mucoid
material, features diagnostic of neuroﬁbroma (Fig. 2). No
anaplastic features were present to indicate malignancy. The ﬁnal
pathological diagnosis was plexiform neuroﬁbroma. Pediatric
genetic consultation did not reveal additional ﬁndings of NF-1.
She was found to lack the typical signs of NF-1 with absence of
Lisch nodules, cafe´-au-lait spots, optic gliomas, multiple other
neuroﬁbromas or axillary/inguinal freckling. With clinical exclu-
sion of NF-1, she was determined to have a solitary, non-syndromic
plexiform neuroﬁbroma. The surveillance of the patient will
include follow-up every 6 months for the ﬁrst year, then annually
for 5 years.
3. Discussion
When evaluating a forehead mass, the differential diagnosis can
be quite broad, and includes hematoma, abscess, lipoma,
arteriovenous malformation, pilomatrixoma, sebaceous cysts,
and malignant entities. In the setting of a patient without obvious
signs of NF-1, the diagnosis of a plexiform neuroﬁbroma typically
does not cross the mind of the clinician.
Diagnostic work-up in our patient included ultrasound imag-
ing. Of note, imaging modalities such as CT/MRI should be
considered if multiple head/neck lesions are suspected or formasses ﬁxed to underlying bone. In our patient however, given the
mobile nature of the mass and low clinical suspicion of additional
lesions on physical examination, additional imaging was not
pursued. MRI would have allowed evaluation of the extent of
tumor into the foramen, but may have required an anesthetic for
child’s examination. In general, radiation exposure is minimized
(CT scan). If the mass was ﬁxated to the frontal bone, a CT may have
been considered. The increasing evidence of risks of radiation
exposure in pediatric patients, may limit the use of CT imaging in
these cases [5].
Plexiform neuroﬁbromas originate from a proliferation of nerve
sheath cells, extending across the length of the nerve, often
involving multiple nerve fascicles, and ultimately creating a mass
of thickened nerve branches [6]. Under a microscope, these lesions
are composed of a variety of elements including Schwann cells,
collagen, ﬁbroblasts, vascular cells and mast cell inﬁltrate as seen
in Fig. 2.
Plexiform neuroﬁbromas are a more aggressive subtype of
neuroﬁbroma, inﬁltrating through the soft tissue to grow along the
length of the affected nerve. If the face is involved, signiﬁcant
disﬁgurement may be seen during the ﬁrst three years of life [7].
These lesions can be seen throughout the body, including the head/
neck region. The trigeminal nerve and its smaller branches are the
most likely cranial nerves to be affected and involvement of the
ophthalmic branch may cause proptosis or other disﬁguring
consequences as the tumor grows within the eyelid or orbit [6].
Occasionally, plexiform neuroﬁbromas may develop into malig-
nant peripheral nerve sheath tumors, which confers a poor
prognosis to the patient [1].
Removal of the lesion is difﬁcult due the signiﬁcant
inﬁltration of surrounding tissues and requires surgery for
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more likely in cases presenting in the head/neck, two times more
likely to recur if resected prior to 10 years old, and two times
more likely to recur in a subtotal versus total resection [8].
However, new modalities of treatment including Imatinib
mesylate have shown promise in reducing tumor volume and
activity, providing not only symptomatic, but therapeutic relief
to the patient [7].
Plexiform neuroﬁbromas are described to be heavily linked
to NF-1. According to previous literature, their presence in an
individual was described to be ‘‘pathognomonic’’ for NF-1 [9].
However, more recent papers suggest that this linkage may not
be as strong as once thought; similar case reports have
described isolated plexiform neuroﬁbromas of the oropharynx,
tongue, orbit, tip of nose, and palm in the absence of signs of
NF-1 [10–12].
Our case was unusual in that it presented without family
history or further systemic symptoms as described above. To our
knowledge, the location of the plexiform neuroﬁbroma located
on the supraorbital nerve has not been described in the
literature. Although the tumor is rare, it should be considered
in the differential diagnosis for a supraorbital subcutaneous
mass.
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